立即登录 | 免费注册
全部学科 | 内科学 | 心血管病学 | 内分泌学与糖尿病 | 神经病学 | 消化病学 | 呼吸病学 | 肿瘤学 | 妇产科学 | 骨科学
疾病中心： 高血压 | 冠心病 | 心力衰竭 | 心律失常 | 脂肪性肝病 | 糖尿病 | 卒中 | 慢性阻塞性肺病 | 子宫内膜异位症 | 乳腺癌 | 肺癌 | 结直肠癌 | 器官移植
Loading
当前位置：期刊中心 > 中国作者重要发表 > 文摘导读

首都钢铁公司和房山社区高血压和心血管疾病的干预

Hypertension and cardiovascular diseases intervention in the capital steel and iron company and Beijing Fangshan community
Chen J., Wu X., Gu D.   |   2009/5/29 18:38:57 
Obesity Reviews, 2008   |   Volume 9, Issue 1  |   打印| 推荐给好友
上一篇: 肿瘤坏死因子相关凋亡诱导DJ-1配体所致的甲状腺癌细胞凋亡的调节
下一篇: 谷氨酸通过N -甲基- D -天门冬氨酸受体介导的高氧性新生大鼠肺损伤
Two intervention studies are described involving >110 000 subjects in each. The first was in a steel factory where one intervention site had health promotion, aimed at altering diet, and particularly reducing salt and fat intake, modest alcohol drinking and smoking cessation, together with a high-risk strategy of hypertension control. The second study involved similar population and high-risk strategies in three of five rural communities. Significant reductions occurred in both intervention and control factory sites in blood pressure, with greater falls in the intervention site, together with a marked additional reduction in salt intake and better control of hypertension. In the rural communities, blood pressure fell in all communities to a more modest degree than in the factory, but with greater blood pressure falls, together with greater smoking cessation and more modest alcohol drinking in the intervention compared with the control communities. Stroke mortality fell by 74.3% and all strokes morbidity by 54.7% in the steel factory as a whole. In the rural communities, the intervention sites showed significantly greater falls in stroke rates than in the control communities. These data show the value and effectiveness of combining a population and high-risk strategy for controlling blood pressure and cardiovascular diseases in both a rural setting and in the work place in China. © 2007 The Authors.
Correspondence Address: Gu, D.; Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; email: gudongfeng@vip.sina.com 
关键词:

请登录后发表评论，点击此处登录。

慢性心衰诊治：规范中求突破
黄峻
2012-2-1
南京医科大学第一附属医院
房颤治疗：手段渐趋丰富 新型治疗药物不断涌现 非药物治疗备受关注
马长生
2012-2-1
首都医科大学附属北京安贞医院
注重老年人群特征 优化管理

刘梅林
2012-2-1
北京大学第一医院老年内科

 
相关文章

关注糖尿病，聚焦GLP-1！案例征集大赛
时间：2011-3~~2011-11
由中国医师协会主办、礼来国际贸易（上海）有限公司协办、爱思唯尔国际出版集团承办的“精彩案例我分享——关注糖尿病•聚焦GLP-1”案例征集活动将于2011年3月~ 11月在全国范围隆重展开。

关注青光眼患者， 让世界更明亮！
时间：2011-4~~2011-12
《中华眼科杂志》发起，辉瑞制药资助，旨在交流青光眼治疗理念，分享国内抗青光眼药物固定联合治疗经验的病例交流活动.

聚焦哮喘和COPD联合制剂治疗
时间：2010-12~~2011-12
哮喘和慢性阻塞性肺疾病（COPD）是常见、多发的气道炎症性疾病，这类疾病严重影响患者的生活质量。我们特别组织了该类案例征集活动，奖品丰厚，快来参与！

中国选择 达标看我
时间：2011-9~~2012-9
本次活动对典型病例以分享的形式总结临床经验，通过跨专科、多层次的学术交流，对降压治疗方案、疗效进行解析与点评。